Lepelletier Didier, Corvec Stéphane, Caillon Jocelyne, Reynaud Alain, Rozé Jean-Christophe, Gras-Leguen Christèle
Department of Bacteriology and Infection Control, Nantes University Hospital, Nantes, France.
Am J Infect Control. 2009 Apr;37(3):195-200. doi: 10.1016/j.ajic.2008.09.024. Epub 2009 Jan 31.
Various strategies for controlling methicillin-resistant Staphylococcus aureus (MRSA) outbreaks in neonatal intensive care units (NICUs) have been tried, with varying levels of success. We report a MRSA outbreak occurring between April 2004 and August 2007 in a 24-bed NICU in a large university hospital. We describe the difficulties involved in implementing measures to control the MRSA outbreak and the possible contribution of each measure.
Cases were defined as neonates with MRSA obtained from either clinical cultures or surveillance cultures (from the anterior nares). Systematic screening of neonates for colonization was performed only between February and December 2005. Successive control strategies included barrier precaution and isolation in individual rooms, mupirocine ointment for neonates and health care workers, cohort isolation, hand hygiene observation, and staff training.
During the routine surveillance culture period (February to December 2005; 48 weeks), 46 neonates were found to be positive for MRSA and were treated with mupirocin. After December 2005, the outbreak was controlled, but the ongoing spread was not eradicated; 9 sporadic MRSA cases were detected by clinical culture up to August 2007.
The widespread use of mupirocine in staff and patients did not control the outbreak and is not recommended. The later control appeared to coincide with increased hand hygiene audits and training for staff, along with appropriate cohort isolation of neonates and cohort nursing.
已尝试多种控制新生儿重症监护病房(NICU)耐甲氧西林金黄色葡萄球菌(MRSA)暴发的策略,成效各异。我们报告了2004年4月至2007年8月期间在一家大型大学医院拥有24张床位的NICU发生的MRSA暴发事件。我们描述了实施控制MRSA暴发措施所涉及的困难以及每项措施可能发挥的作用。
病例定义为从临床培养物或监测培养物(来自前鼻孔)中分离出MRSA的新生儿。仅在2005年2月至12月期间对新生儿进行了系统性定植筛查。相继采取的控制策略包括屏障预防和单间隔离、对新生儿和医护人员使用莫匹罗星软膏、群组隔离、手部卫生观察以及工作人员培训。
在常规监测培养期(2005年2月至12月;48周),发现46例新生儿MRSA检测呈阳性,并接受了莫匹罗星治疗。2005年12月之后,暴发得到控制,但持续传播未根除;截至2007年8月,通过临床培养又检测到9例散发性MRSA病例。
在工作人员和患者中广泛使用莫匹罗星未能控制暴发,不建议使用。后期的控制似乎与加强手部卫生审核和工作人员培训以及对新生儿进行适当的群组隔离和群组护理同时出现。